Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.

Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2015 Feb 01; 91(2):344-50.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung
Dose-Response Relationship, Radiation
Female
Humans
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Prevalence
Radiosurgery
Radiotherapy Dosage
Registries
Relative Biological Effectiveness
Risk Factors
Survival Rate
Treatment Outcome
United States

authors with profiles

Ralph R. Weichselbaum
Matthew Koshy